Posted On: Mar-2022 | Categories : Healthcare
Nowadays, disease in the intestine has become a common trend in people's lives. It can be due to a low fiber diet, being stressed, not drinking sufficient water, eating a lot of dairy foods, an inactive lifestyle, aging, etc. It is for this reason, investigation in the intestines, as well as the inner part of the rectum, should be deeply investigated. The entire process of endoscopy in these regions is termed colonoscopy. The colonoscopy process helps the doctor examine the whole intestine and the lower part of the rectum deeply, which will further help the doctor figure out the exact problem within. Besides these, colon cancer occurs in the intestinal regions of the body. With the help of the colonoscopy, the physician can monitor or screen the affected area in the lining of the colon and rectum.
As per the National Institute of Health, colon cancer is the 3rd leading reason behind cancer death in the U.S. from any precancerous growths (polyps), which causes colon cancer.
Read More About Colonoscopy Devices Market Report Here
The new AI-enhanced endoscopy aid device, GI Genius, is made to assist the doctors in recognizing any lesion in real-time scenarios during the entire process of colonoscopy. Hence this device will make the work easier for the doctors in examining the lower part of the digestive tract and the inner portion of the intestinal areas.
Artificial intelligence is the next upcoming future. Moreover, since GI Genius uses artificial intelligence technology, this device possesses the full potential to find and figure out the problem a bit earlier. Hence if the problem can be identified earlier, it would be much easier for the doctors to resolve it efficiently. Therefore it makes the work much more manageable when AI comes into screening methods in the healthcare industry.
As per the research, it is evident that there is a missing out of the lesions at screening colon cancer. Even professionals have faced the same problem. But as AI has come into existence in terms of screening the lesions, there won't be any chance of missing the lesions, and the results that will be coming will be trustworthy.
On the 13th of April, 2021, GI Genius was approved by the U.S. FDA (Food and Drug Administration). So it became the first device to use AI in detecting the possible signs of colon cancer during colonoscopy. This is where it enables the clinicians to do their job more accurately and in a reliable way. So now, the detection of colon lesions will be more accessible than ever.
In addition, within the device, GI Genius contains the software using AI methods, enabling the doctor about the aspects like the clear visual screening, accurate details about the affected areas, tissue sampling, the status of the lesion, and other crucial parameters.
Follow us on Twitter Facebook Linkedin Instagram